Alzheimer’s disease as a window to neural mechanisms of cognition
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Two articles in this issue of Neurology focus on neuropsychological studies in Alzheimer’s disease (AD). Using voxel-based MRI morphometry, Boxer et al.1 report a strong association between impaired copying performance on a modified version of the Rey–Osterrieth figure and gray matter loss in the right inferior temporal gyrus in AD. Monacelli et al.2 report a novel test of visuospatial learning in which subjects traverse a route through a complex environment. They find that a tendency to become lost is most strongly predicted by failure on a test of route learning that requires subjects to recall the visuospatial configurations at turning points and to place them in a mental map of the route. Both studies exemplify the use of AD as a lesion model to better understand the neural basis of cognitive function. Although somewhat cumbersome, the highly original test developed by Monacelli et al. holds promise as a sensitive early clinical marker of AD.
By testing the ability of their subjects to copy a modified version of the Rey–Osterrieth figure, Boxer et al. probed the function of the “what” visual pathway in a topographic domain (stimulus elements related to each other in terms of spatial configuration rather than sequence), thereby engaging the “what” pathway in the right hemisphere.3 Consequently, their findings are logical. Moreover, they have provided empirical validation that has not been possible with other lesion models. Patients with right hemisphere (middle cerebral artery distribution) strokes commonly demonstrate constructional apraxia characterized by detailed but disorganized drawings that often fail to capture the gestalt of the target.4 However, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Neuroanatomic correlates of visual agnosia in Alzheimer’s diseaseA clinicopathologic studyP. Giannakopoulos, G. Gold, M. Duc et al.Neurology, January 01, 1999 -
Articles
Clinical syndromes associated with posterior atrophyEarly age at onset AD spectrumR. Migliaccio, F. Agosta, K. Rascovsky et al.Neurology, November 09, 2009 -
Articles
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distributionM.H. Rosenbloom, A. Alkalay, N. Agarwal et al.Neurology, April 27, 2011 -
Articles
CSF biomarkers in posterior cortical atrophyJ. Seguin, M. Formaglio, A. Perret-Liaudet et al.Neurology, April 27, 2011